ARRY-797

CAS No. 1036404-17-7

ARRY-797( ARRY-371797 | ARRY-797 )

Catalog No. M28777 CAS No. 1036404-17-7

ARRY-797 is a potent and selective p38α inhibitor and inhibits LPS-Induced IL-6.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 131 Get Quote
10MG 218 Get Quote
25MG 385 Get Quote
50MG 655 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ARRY-797
  • Note
    Research use only, not for human use.
  • Brief Description
    ARRY-797 is a potent and selective p38α inhibitor and inhibits LPS-Induced IL-6.
  • Description
    ARRY-797 is a potent and selective p38α inhibitor and inhibits LPS-Induced IL-6.(In Vivo):ARRY-797 inhibits the growth of RPMI-8226 Human Multiple Myeloma Cells. ARRY-371797 prevented left ventricular dilatation and deterioration of fractional shortening compared with placebo-treated mice.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ARRY-371797 | ARRY-797
  • Pathway
    Apoptosis
  • Target
    IL Receptor
  • Recptor
    Microtubule/Tubulin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1036404-17-7
  • Formula Weight
    ——
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.An W, et al. Discovery of novel 2-phenyl-imidazo[1,2-a]pyridine analogues targeting tubulin polymerization as antiproliferative agents. Eur J Med Chem. 2016 Apr 13;112:367-372.
molnova catalog
related products
  • 5-O-Caffeoylshikimic...

    5-O-Caffeoylshikimic acid shows anti-oxidative activity; it also shows anti-inflammatory activity, the underlying mechanism was associated with downregulation of nuclear factor-κB.

  • GSK717

    GSK717 is a potent and selective inhibitor of nucleotide-binding oligomerization domain 2 (NOD2). GSK717 blocks synergy between NOD2 and TLR2. GSK717 does not affect NOD1, TNFR1 and TLR2-mediated responses.

  • PF-07038124 HCl

    PF-07038124 HCl is a selective and potent PDE4 inhibitor with an IC50 of 0.5 nM for PDE4B2.PF-07038124 HCl inhibits IL-13, IL-4, and IFNγ, and can be used in the study of skin disorders such as atopic dermatitis and plaque psoriasis.